Cargando…
Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
BACKGROUND: There is a paucity of contemporary data assessing the implications of atrial fibrillation (AF) on major adverse cardiovascular events (MACE) in patients with or at high‐risk for atherosclerotic disease managed in routine practice. HYPOTHESIS: We sought to evaluate the 4‐year incidence of...
Autores principales: | Miao, Benjamin, Hernandez, Adrian V., Roman, Yuani M., Alberts, Mark J., Coleman, Craig I., Baker, William L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244295/ https://www.ncbi.nlm.nih.gov/pubmed/32106334 http://dx.doi.org/10.1002/clc.23344 |
Ejemplares similares
-
Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors
por: Miao, Benjamin, et al.
Publicado: (2020) -
Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events
por: Guédon, Alexis F., et al.
Publicado: (2022) -
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
por: Bonora, Benedetta Maria, et al.
Publicado: (2021) -
Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
por: Chan, Yi-Hsin, et al.
Publicado: (2020) -
Age at Diagnosis of Atrial Fibrillation and Incident Dementia
por: Zhang, Wenya, et al.
Publicado: (2023)